Sofinnova Investments, Inc. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.06 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $197M, Vera Therapeutics, Inc. with a value of $123M, Novo Nordisk A S with a value of $86.5M, Astrazeneca PLC with a value of $63.1M, and Ideaya Biosciences, Inc. with a value of $55.4M.

Examining the 13F form we can see an decrease of $745M in the current position value, from $1.8B to 1.06B.

Sofinnova Investments, Inc. is based out at Menlo Park, CA

Below you can find more details about Sofinnova Investments, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $1.06 Billion
Healthcare: $1.06 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $1.06 Billion
  • Prior Value $1.8 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.